Member Info for Poundcake

Spot on. Peasant...

The tweet referred to ‘Clinical evaluation’... John bell is talking about validation in another sense imo.

Looks indeed like he is out, older and wiser is clearly back in now rambling the balls off it on twitter. Remarkable stuff.

And let’s not forget... if the LFT works then affimers work... and the concept is proven which, long term, is worth many multiples of the LFT!

This of course assumes avacta has not made a single test since July.

Now, I’m not saying we will be part of the 6 tomorrow (as no 10k batch) but the concept that the gov, and John bell do not have an idea as to avacta LFT performance is for the birds.

Let’s not forget Alastair saying ‘it works’..... now tech transfer... the housing... etc all need to be perfected for MASS TESTING but... the strip, which is the core of it... has been ‘frozen’ for a long time I would imagine. You would like to think they have tested test for s&s and it is the mass produced version which I seeking to tweak the product.

Let’s not forget the Liverpool school of tropical medicine were said to be validating it too!

Will be fascinating to see the list tomorrow whether we even get a mention or not!

Same chap who called out those ‘reagents’ don’t forget... I heard affimer when he said that!

So...6 LFT validation results being announced tomorrow.

Don’t see how it can be us, but equally... I’d like to think they have at least one test (not the kind being mass produced) from the past 6+ months to enable some form of validation.

We shall see.

Best news of day is ft picking up on 43bn being ploughed into testing.

Remarkable this still trades below placing price. Truly remarkable.

Here was my email to big al... sent at 10.22:

“ Remarkable you have chosen not to reassure investors.

If there is indeed still a government contract in the offing, the base is now half of where we were a few weeks ago and 30% below placing.

I simply do not understand the logic of this decision.”

so I’ll claim credit for his twitter spree.

Thanks in advance

So....

Down 20%

Up again after avacta find some PR skills (first time I have genuinely been exasperated with mgmt I might add)

The holy grail vaccine will take months if not years to roll out, oh and we don’t have enough fridges....

Ft reports govn will pump 43bn into testing

John bell moots idea of at home lfts being given to positive isolators

John bell says he will release the 6 tests tomorrow (no idea whether we have a single test which has been validated in this respect but waiting on 10k batch to see if they meet the same threshold)

Avacta confirm bams due shortly.... significant commercial opportunities

Same for lft....

F*** me... have I forgotten anything?

Oh yes, older and wiser plus Hardy are clearly both back in and ramping the balls off avacta on twitter.

Remarkable stuff.

Get us into Nasdaq ASAP!

Government to spend £42bn on private testing contracts
The sum is equivalent to the UK’s annual defence budget and involves contracts awarded on behalf of Public Health England and the NHS

Keep bumping this all day long.

It’s quite clear the green light has been given on testing and that must mean avacta.

Government to spend £42bn on private testing contracts
The sum is equivalent to the UK’s annual defence budget and involves contracts awarded on behalf of Public Health England and the NHS

NORMALITY BY THE SPRING? John Bell, regius professor of medicine at Oxford University, set the hare running on the BBC’s World at One yesterday when he claimed the vaccine could see life return to normal by the spring. Playbook asked a DoH official if Han**** agreed with that assessment last night, and they notably did not repeat it: “The health secretary hopes life can return to normality as quickly as possible. The best way of helping achieve that is by everyone sticking to the rules and controlling the spread.” A Whitehall source described Bell’s spring prediction as “totally batsh*t” and said it was likely that some social distancing measures would have to continue until the summer at the earliest.

Govn insiders telling politico population wide testing will come before the vaccine

As you were

DON’T FORGET MOONSHOT MATT: Some government insiders are also questioning whether it is the vaccine that will get Britons back to normality. The government’s priority until now has been its “Moonshot” mass-testing program. A Whitehall source told Playbook last night that population-wide repeat mass-testing remains the quickest and most viable route to ending COVID restrictions, and is likely to be in place well before the vaccine can be given to the whole country.

No Opinion
RE: Pfizer complicationsToday 03:48
Pfizer trial: 94 patients of 43,358 contracted Covid-19; of those 94, eight had received the vaccine and 86 had received a placebo.

Yes you read that right...

Some sense will kick in today, question is, how much? Wouldn’t surprise me to be back to where we were come Friday.

Pfizer trial: 94 patients of 43,358 contracted Covid-19; of those 94, eight had received the vaccine and 86 had received a placebo.

Yes you read that right....

Should never have fallen (at all!)

Still don’t think it’s going to innova....

Easy to forget that after the vaccine today

Yep, it was very helpful pl. I feel the same!

Old Myles writing and then deleting tweets just now. Very odd. Saw 3/5 then poof....

Gone!

Personally, my PF took an almighty hit, owing to #AVCT being my largest position by a log way, and also having a recent position in #SNG.

“A high quality vaccine was always the key risk to #COVID19 plays, but for me, that has always been a medium term risk.

3/5”

The more I digest and sit back the more I wonder how the feck this ended 35% down today.

No doubt compounded by stop loss triggers. My IG position got stopped out which I thought was safe at 125p.

Still. Remarkable.

Q30: When a vaccine is developed for coronavirus will there still be a demand for saliva testing?
Vaccines are still in development and when the first ones become available it will take a considerable time to vaccinate a significant proportion of the global population before there is an impact on the need for testing. Furthermore, the level of efficacy of any vaccine, and duration of protection afforded, will influence demand for testing in the future. There will also likely be an ongoing, but much reduced need for testing once a global vaccination programme has been successfully completed.